glp 1 microdose Microdosing of GLP-1's / Wellness Services / Services What Is Microdosing GLP-1? Full
Description
A 2024 RCT found semaglutide reduced hip bone density by 2.6% and lumbar spine by 2.1% in one year

Since type 2 diabetes mellitus (T2DM) is a risk factor for Alzheimers disease (AD) and both have the same pathogenesis (e.g., insulin resistance), drugs used to treat T2DM have been gradually found to reduce the progression of AD in AD models
Manifestations can vary from isolated liver enzyme elevation to fulminant hepatic failure

Williams emphasi

Diabetic peripheral neuropathy (DPN) is one of the complications of diabetes...

In conjunction with all the effects, GLP-1 RAs have been found to lower weight and aid in weight management.
